The hypoxia-inducible factor-1α is a negative factor for tumor therapy

Oncogene

Volumn 22, Issue 21, 2003, Pages 3213-3220

  Unruh, Annika ^a   Ressel, Anke ^a   Mohamed, Hamid G ^a   Johnson, Randall S ^b   Nadrowitz, Roger ^a   Richter, Eckart ^a   Katschinski, Dörthe M ^a,d   Wenger, Roland H ^c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Chemotherapy resistance; Glycolysis; Transcriptional gene regulation; Tumor irradiation; Tumor oxygenation

Indexed keywords

CARBOPLATIN; ETOPOSIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; ENZYME INHIBITOR; IRON CHELATING AGENT; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER; CARCINOGENESIS; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; DNA HELIX; DNA STRAND BREAKAGE; DNA SYNTHESIS; DRUG RESISTANCE; EMBRYO; FIBROSARCOMA; GAMMA IRRADIATION; GENOTYPE; IMMUNE DEFICIENCY; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; TRANSCRIPTION REGULATION; ANIMAL; APOPTOSIS; CELL LINE; DNA REPAIR; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; GENE DELETION; GENETICS; MALE; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CELL LINE, TRANSFORMED; DNA REPAIR; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; GENE DELETION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON CHELATING AGENTS; MALE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038282482     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206385     Document Type: Article

References (54)

1. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH and Semenza GL. (2001). Cancer Res., 61, 2911-2916.
2. Alarcón R, Koumenis C, Geyer RK, Maki CG and Giaccia AJ. (1999). Cancer Res., 59, 6046-6051.
3. Ali SH and DeCaprio JA. (2001). Semin. Cancer Biol., 11, 15-23.
4. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM. (1998). Nature, 392, 405-408.
5. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G and Oberhuber G. (2000). Cancer Res., 60, 4693-4696.
6. Brown JM. (2000). Mol. Med. Today, 6, 157-162.
7. Brown JM and Giaccia AJ. (1998). Cancer Res., 58, 1408-1416.
8. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D and Keshet E. (1998). Nature, 394, 485-490.
9. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC and Colgan SP. (2002). Cancer Res., 62, 3387-3394.
10. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ and Ratcliffe PJ. (2001). Cell, 107, 43-54.
11. Farinelli SE and Greene LA. (1996). J. Neurosci., 16, 1150-1162.
12. Gao J and Richardson DR. (2001). Blood, 98, 842-850.
13. Gassmann M, Kvietikova I, Rolfs A and Wenger RH. (1997). Kidney Int., 51, 567-574.
14. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. (1996). Nature, 379, 88-91.
15. Griffiths JR, McSheehy PM, Robinson SP, Troy H, Chung YL, Leek RD, Williams KJ, Stratford IJ, Harris AL and Stubbs M. (2002). Cancer Res., 62, 688-695.
16. Hammond EM, Denko NC, Dorie MJ, Abraham RT and Giaccia AJ. (2002). Mol. Cell. Biol., 22, 1834-1843.
17. Hansen MB, Nielsen SE and Berg K. (1989). J. Immunol. Methods, 119, 203-210.
18. Harris AL. (2002). Nat. Rev. Cancer, 2, 38-47.
19. Höckel M, Schlenger K, Höckel S and Vaupel P. (1999). Cancer Res., 59, 4525-4528.
20. Höckel M and Vaupel P. (2001). J. Natl. Cancer Inst., 93, 266-276.
21. Höpfl G, Wenger RH, Ziegler U, Stallmach T, Gardelle O, Achermann R, Wergin M, Kaser-Hotz B, Saunders HM, Williams KJ, Stratford IJ, Gassmann M and Desbaillets I. (2002). Cancer Res., 62, 2962-2970.
22. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F and Neckers LM. (2002). J. Biol. Chem., 277, 29936-29944.
23. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin Jr WG. (2001). Science, 292, 464-468.
24. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY and Semenza GL. (1998). Genes Dev., 12, 149-162.
25. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW and Ratcliffe PJ. (2001). Science, 292, 468-472.
26. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH and Gassmann M. (2001). FASEB J., 15, 1312-1314.
27. Jiang BH, Agani F, Passaniti A and Semenza GL. (1997). Cancer Res., 57, 5328-5335.
28. Jiang BH, Semenza GL, Bauer C and Marti HH. (1996). Am. J. Physiol., 271, C1172-1180.
29. Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG and Wenger RH. (2002). J. Biol. Chem., 277, 9262-9267.
30. Katschinski DM, Robins HI, Schad M, Frede S and Fandrey J. (1999). Cancer Res., 59, 3404-3410.
31. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turtey H, Talks K, Gatter KC and Harris AL. (2002). Int. J. Radiat. Oncol. Biol. Phys., 53, 1192-1202.
32. Krieg M, Haas R, Brauch H, Acker T, Flamme I and Plate KH. (2000). Oncogene, 19, 5435-5443.
33. Kung AL, Wang S, Klco JM, Kaelin WG and Livingston DM. (2000). Nat. Med., 6, 1335-1340.
34. Lederman HM, Cohen A, Lee JW, Freedman MH and Gelfand EW. (1984). Blood, 64, 748-753.
35. Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW and Zhong H. (2002). Cancer Res., 62, 2478-2482.
36. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW and Ratcliffe PJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 8104-8109.
37. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ. (1999). Nature, 399, 271-275.
38. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V and Caro J. (2002). J. Biol. Chem., 277, 6183-6187.
39. Mosmann T. (1983). J. Immunol. Methods, 65, 55-63.
40. Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH and Melillo G. (2002). Cancer Res., 62, 4316-4324.
41. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A. (2000). Genes Dev., 14, 34-44.
42. Ryan HE, Lo J and Johnson RS. (1998). EMBO J., 17, 3005-3015.
43. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS. (2000). Cancer Res., 60, 4010-4015.
44. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K and Johnson RS. (2001). Mol. Cell. Biol., 21, 3436-3444.
45. Semenza GL. (2000). Crit. Rev. Biochem. Mol. Biol., 35, 71-103.
46. Semenza GL. (2002). Trends Mol. Med., 8, S62-S67.
47. Vaupel P, Thews O and Höckel M. (2001). Med. Oncol., 18, 243-259.
48. Wang GL, Jiang BH, Rue EA and Semenza GL. (1995). Proc. Natl. Acad. Sci. USA, 92, 5510-5514.
49. Wanner RM, Spielmann P, Stroka DM, Camenisch G, Camenisch I, Scheid A, Houck DR, Bauer C, Gassmann M and Wenger RH. (2000). Blood, 96, 1558-1565.
50. Wenger RH. (2002). FASEB J., 16, 1151-1162.
51. Wenger RH, Camenisch G, Desbaillets I, Chilov D and Gassmann M. (1998). Cancer Res., 58, 5678-5680.
52. Williams KJ, Telfer BA, Airley RE, Peters HP, Sheridan MR, van der Kogel AJ, Harris AL and Stratford IJ. (2002). Oncogene, 21, 282-290.
53. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW. (1999). Cancer Res., 59, 5830-5835.
54. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D and Giaccia AJ. (2000). Genes Dev., 14, 391-396.